You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Active immune therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

Recruiting
  • Secondary Hemophagocytic Lymphohistiocytosis
  • Chronic Active Epstein-Barr Virus Infection
  • No intervention
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
May 2, 2023

Immune Health Trial (High dose Human Lactoferrin, Low dose Human Lactoferrin, Active Control Bovine Lactoferrin)

Not yet recruiting
  • Immune Health
  • High dose Human Lactoferrin
  • +2 more
  • (no location specified)
Aug 25, 2023

Covid-19 Patients Trial in Giza (Cupping therapy with convential medical treatment, Convential medical treatment)

Completed
  • Covid-19 Patients
  • Cupping therapy with convential medical treatment
  • Convential medical treatment
  • Giza, Egypt
    Faculty of physical therapy
Jun 11, 2023

HIV Trial in Iowa City, New York (Tetanus Toxoid Vaccine, Hepatitis A Vaccine (Inactivated), HIV-1 Immunogen)

Completed
  • HIV Infections
  • Tetanus Toxoid Vaccine
  • +3 more
  • Iowa City, Iowa
  • +1 more
Oct 27, 2021

Immune System Disorder Trial in Giza (Aerobic training, diet protocol)

Recruiting
  • Immune System Disorder
  • Aerobic training
  • diet protocol
  • Giza, Egypt
    Faculty of Physical therapy, Cairo University
Nov 20, 2023

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)

Active, not recruiting
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
May 17, 2023

Hepatitis Immune Trial (Active Surveillance, Early initiation)

Not yet recruiting
  • Hepatitis Immune
  • Active Surveillance
  • Early initiation
  • (no location specified)
Jul 14, 2022

AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)

Recruiting
  • AIDS Virus
  • Disorder of Immune Reconstitution
  • normal saline
  • Mesenchymal stem cells
  • Jinan, Shandong, China
    Shandong Public Health Clinical Center
May 14, 2023

Last Period Not Earlier Than 6 Months Ago Trial in Moscow (oral menopausal hormone therapy, transdermal menopausal hormone

Active, not recruiting
  • Last Period Not Earlier Than 6 Months Ago
  • oral menopausal hormone therapy
  • transdermal menopausal hormone therapy
  • Moscow, Russian Federation
    Federal State Budget Institution Research Center for Obstetrics,
Jan 9, 2023

Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)

Recruiting
  • Actinic Keratosis
  • Photodynamic Therapy
  • Celecoxib 200mg
  • Placebo
  • Fairborn, Ohio
    Wright State Physicians
Jan 9, 2023

Recovery From Acute Immune Failure in Septic Shock by Immune

Recruiting
  • Severe Sepsis
    • Magdeburg, Germany
    • +1 more
    Nov 20, 2023

    Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)

    Not yet recruiting
    • Immune-related Colitis
    • Colitis
    • Minneapolis, Minnesota
      University of Minnesota
    Feb 4, 2023

    Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome Trial in Orange (CAB-201 following preconditioning

    Recruiting
    • Idiopathic Inflammatory Myopathy
    • +3 more
    • CAB-201 following preconditioning with fludarabine and cyclophosphamide
    • Orange, California
      University of California Irvine
    Nov 30, 2023

    Neoadjuvant Therapy in Rectal Cancer

    Recruiting
    • Rectal Cancer
    • Immune checkpoint measure
    • Istanbul, Turkey
      Istanbul Training and Research Hospital
    Jul 9, 2022

    Hamstring Injuries Trial in Ávila (Passive Neurodynamics and Passive axial hip mobilisation/distraction, Active therapy, 2.5.3.

    Completed
    • Hamstring Injuries
    • Passive Neurodynamics and Passive axial hip mobilisation/distraction
    • +2 more
    • Ávila, Spain
      Universidad Católica de Ávila
    Mar 16, 2023

    Lung Cancer Stage IV Trial in Maastricht (Radiation)

    Not yet recruiting
    • Lung Cancer Stage IV
    • Radiation
    • Maastricht, Netherlands
      Maastricht Radiation Oncology (Maastro)
    Aug 29, 2023

    Immune Checkpoint Inhibitor Monotherapy or Combined With

    Not yet recruiting
    • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    Jan 30, 2023

    Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Stereotactic body radiotherapy (SBRT)
    • +4 more
    • New York, New York
      Columbia University Irving Medical Center
    Sep 15, 2023

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Gemtuzumab Ozogamicin
    • Valhalla, New York
      New York Medical College
    Sep 26, 2022

    Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Cryoablation
    • Cryoablation combined with PD1 Inhibitor
    • (no location specified)
    Mar 28, 2023

    Immune-related Adverse Events Refractory to Standard Therapy and

    Recruiting
    • Immune-related Adverse Event
    • Extracorporeal photopheresis
    • Other immunosuppressive or immunomodulatory drugs
    • Munich, Germany
      LMU Klinikum Hauttumorzentrum
    Jan 17, 2023

    Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

    Completed
    • Gastrointestinal Tumor
    • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
    • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
    • Hangzhou, China
      Zhejiang Hospital
    Sep 1, 2023

    Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,

    Recruiting
    • Breast Cancer
    • +2 more
    • Taipei City, Taiwan
    • +1 more
    Mar 15, 2023

    Adjuvant Immune Checkpoint Inhibitors in Postoperative

    Recruiting
    • Hepatocellular Carcinoma
    • Immune Checkpoint Inhibitors Based Adjuvant therapy
    • Nanning, Guangxi, China
      Jian-Hong Zhong
    Jan 18, 2023

    Neck Pain, Chronic Pain Trial in Alcalá De Henares (Manual therapy active, Manual therapy)

    Completed
    • Neck Pain
    • Chronic Pain
    • Manual therapy active
    • Manual therapy
    • Alcalá De Henares, Madrid, Spain
      Alexander achalandabaso
    Nov 1, 2022